您当前的位置:
首页 >
文章列表页 >
Experience in managing primary immune thrombocytopenia with high-dose Sangye (Folium Mori)
Theoretical Exploration | 更新时间:2024-11-29
    • Experience in managing primary immune thrombocytopenia with high-dose Sangye (Folium Mori)

    • Modern Chinese Clinical Medicine   Vol. 31, Issue 6, Pages: 104-108(2024)
    • DOI:10.3969/j.issn.2095-6606.2024.06.022    

      CLC: R255.7;R259
    • Received:16 October 2023

      Published:30 November 2024

    移动端阅览

  • LI Shuang, YV Hang, PAN Yanjun, et al. Experience in managing primary immune thrombocytopenia with high-dose Sangye (Folium Mori)[J]. Modern Chinese Clinical Medicine, 2024, 31(6): 104-108. DOI: 10.3969/j.issn.2095-6606.2024.06.022.

  •  
  •  

0

Views

686

下载量

0

CSCD

Alert me when the article has been cited
提交
Tools
Download
Export Citation
Share
Add to favorites
Add to my album

Related Articles

Exploring the application of common external treatments in dermatological diseases from the perspective of the harmonizing method
Clinical experience in treating eczema with He's Triple-Dredging Acupuncture techniques
Analysis of TCM pathogenesis and prevention and treatment strategies for obesity-associated hypertension in children and adolescents based on phlegm,heat and deficiency
Exploration of clinical thinking for bronchial asthma from the perspectives of wind,phlegm and deficiency based on the core concept of Huangdi Neijing
Efficacy of Wenyang Sanhan Qushi Formula for persistent high-risk human papillomavirus infection in women

Related Author

FANG Yun
TENG Zhengwen
YAO Rong
LI Yuanwen

Related Institution

Dongfang Hospital, Beijing University of Chinese Medicine
0